A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131

The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

NCT06902818 ·Status: COMPLETED ·Phase: PHASE1

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.

NCT00206284 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

NCT03211143 ·Status: COMPLETED ·Phase: PHASE1

Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients

NCT00222131 ·Status: COMPLETED ·Phase: PHASE2

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

NCT03980756 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

NCT03444402 ·Status: COMPLETED ·Phase: PHASE1

Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

NCT01390714 ·Status: COMPLETED ·Phase: PHASE1

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

NCT00810485 ·Status: COMPLETED ·Phase: PHASE2

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.

NCT00206245 ·Status: COMPLETED ·Phase: PHASE2

Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

NCT00312806 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Esomeprazole in Patients With Frequent Heartburn

NCT01370538 ·Status: COMPLETED ·Phase: PHASE3

Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI Damage

NCT00524329 ·Status: COMPLETED

A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881

NCT04128787 ·Status: COMPLETED ·Phase: PHASE1

AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

NCT00325715 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of AD-203

NCT04066530 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

NCT06141577 ·Status: COMPLETED ·Phase: PHASE1

A Trial of C13-CAC Breath Test in PPI Resistant GERD Patients

NCT03284177 ·Status: COMPLETED ·Phase: PHASE2

German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms

NCT00567021 ·Status: COMPLETED

Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects

NCT01821521 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

NCT00464308 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

NCT03736369 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare PK, PD and Safety of UI058 and UIC202004 in Healthy Subjects

NCT05282914 ·Status: COMPLETED ·Phase: PHASE1

Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

NCT02423187 ·Status: COMPLETED

A Study to Evaluate the Effect of Gastric pH on Acalabrutinib Pharmacokinetics (PK) in Healthy Adult Participants

NCT04905043 ·Status: COMPLETED ·Phase: PHASE1

An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

NCT00629564 ·Status: COMPLETED ·Phase: PHASE4